Literature DB >> 11815406

Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result.

Valérie Bonadona1, Pierre Saltel, Françoise Desseigne, Hervé Mignotte, Jean-Christophe Saurin, Qing Wang, Olga Sinilnikova, Sophie Giraud, Gilles Freyer, Henri Plauchu, Alain Puisieux, Christine Lasset.   

Abstract

The aim of this prospective study was to evaluate the consequences of the disclosure of a positive genetic test result to patients affected with cancer. Personal repercussions and patients' behavior with the transmission of their results to relatives were considered. We conducted semistructured interviews with 23 cancer patients identified as carriers of a cancer-predisposing mutation for hereditary breast ovarian or nonpolyposis colorectal cancers, 1 month after the disclosure of the test result. Eight patients spontaneously expressed distressed reactions ("you no longer feel cured"), and 14 patients reported at least one negative feeling (dissatisfied, discouraged, unhappy, or worried), despite expecting to be a carrier. Sixteen patients expressed concerns about the risk of developing another cancer, and 18 were concerned for their children's future, in that they may carry the mutation and develop a cancer. Although 8 patients found that disadvantages of knowing their genetic status outweighed the advantages, all but 1 did not regret having undergone genetic testing. All of the patients transmitted their results to at least one close relative. Although 6 of them expressed difficulties in being the only person who could transmit the information and 9 said it was a heavy responsibility, all except 1 did not want someone else to have to inform their families. Our results illustrate the potential negative impact of diagnostic genetic testing in patients with cancer. This includes distressed reactions and difficulties in transmitting their results to relatives. Future large-scale studies are warranted to confirm our findings.

Entities:  

Mesh:

Year:  2002        PMID: 11815406

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  25 in total

Review 1.  Methodology in longitudinal studies on psychological effects of predictive DNA testing: a review.

Authors:  R Timman; T Stijnen; A Tibben
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

2.  The development of a methodology for examining the process of family communication of genetic test results.

Authors:  Jonathan A Smith; Caroline Dancyger; Melissa Wallace; Chris Jacobs; Susan Michie
Journal:  J Genet Couns       Date:  2010-09-11       Impact factor: 2.537

3.  Disclosing cancer genetic information within families: perspectives of counselees and their at-risk relatives.

Authors:  Afsaneh Hayat Roshanai; Claudia Lampic; Richard Rosenquist; Karin Nordin
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

Review 4.  Specific psychosocial issues of individuals undergoing genetic counseling for cancer - a literature review.

Authors:  Willem Eijzenga; Daniela E E Hahn; Neil K Aaronson; Irma Kluijt; Eveline M A Bleiker
Journal:  J Genet Couns       Date:  2013-08-31       Impact factor: 2.537

Review 5.  Are genetic self-tests dangerous? Assessing the commercialization of genetic testing in terms of personal autonomy.

Authors:  Ludvig Beckman
Journal:  Theor Med Bioeth       Date:  2004

6.  Facilitating family communication about predictive genetic testing: probands' perceptions.

Authors:  Clara L Gaff; Veronica Collins; Tiffany Symes; Jane Halliday
Journal:  J Genet Couns       Date:  2005-04       Impact factor: 2.537

7.  Knowledge and expectations of women undergoing cancer genetic risk assessment: a qualitative analysis of free-text questionnaire comments.

Authors:  C Phelps; F Wood; P Bennett; K Brain; J Gray
Journal:  J Genet Couns       Date:  2007-02-23       Impact factor: 2.537

8.  Experiences and decisions that motivate women at increased risk of breast cancer to participate in an experimental screening program.

Authors:  Michelle Proulx; Marie-Dominique Beaulieu; Christine Loignon; Marie-Hélène Mayrand; Christine Maugard; Nathalie Bellavance; Diane Provencher
Journal:  J Genet Couns       Date:  2009-02-14       Impact factor: 2.537

9.  BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy.

Authors:  Kathryn J Schlich-Bakker; Margreet G E M Ausems; Maria Schipper; Herman F J Ten Kroode; Carla C Wárlám-Rodenhuis; Jan van den Bout
Journal:  Breast Cancer Res Treat       Date:  2007-08-03       Impact factor: 4.872

Review 10.  Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda.

Authors:  Bettina Meiser; Kathy Tucker; Michael Friedlander; Kristine Barlow-Stewart; Elizabeth Lobb; Christobel Saunders; Gillian Mitchell
Journal:  Breast Cancer Res       Date:  2008-11-28       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.